The deadline to submitting comments is now closed, so what updates are Argentina’s National Administration of Drugs, Foods and Medical Devices (ANMAT) considering for dietary supplements?
FDA’s new Acting Commissioner of Food and Drugs, Norman Sharpless, promised last week that he will pick up where outgoing Commissioner Scott Gottlieb left off in strengthening nutrition policy and regulation to improve the public’s health and implementing...
Omega-3 pharmaceutical firm Amarin has settled two cases with supplement manufacturers it alleged were using its drug studies to market their fish oil supplements.
A data firm specializing in the cannabis markets predicts the US hemp category could grow more than tenfold by 2024, attendees at a recent event were told.
Fundamental questions of identity and intended use will have to be answered before CBD can take center stage as a legal dietary ingredient. The upcoming meeting with FDA will likely provide a start, but hopes that all issues will be quickly solved seem...
The US Court of Appeals for the Federal Circuit backed the ITC’s refusal to not investigate Amarin Pharma’s complaint alleging that certain doses of omega-3s should not be imported as dietary supplements.
What’s the typical profile of an energy drink consumer in the US, and how much are they drinking? Researchers from the Harvard T.H. Chan School of Public Health analyzed data from a national health survey to get some answers.
‘Designer prebiotics’ have greater potential than probiotics to be able to modify our microbiomes and improve our long-term health, according to the founder and CEO of a trailblazing life science firm.
Global ingredient supplier Seppic has received the green light from Canada’s health authority to market its phytoceramide ingredient using several skin health claims.
Nutrition guidelines must ask the right questions and include a degree of complexity to improve their relevance and quality, according to a research team writing in the BMJ.
Despite recent griping about the utility of structure/function claims, they do convey useful information to consumers, in the opinion of a prominent expert in the botanicals field.
The Center for Science in the Public Interest (CSPI) sent a letter to the FDA yesterday, asking the agency to take enforcement action against 15 companies selling products as dietary supplements to help smokers quit.
The recent slew of warning letters on DMHA and phenibut signals a new scrutiny on the part of FDA of ingredient status without reference to other issues, says an attorney with a long history in the field.
It’s a global industry and there’s a lot happening. We know it’s not always easy keeping up with everything that’s happening around the world that could impact the US dietary supplements industry. The answer? Our weekly round-up of key news from across...
While the FDA issued alerts and marketing materials for consumers to understand mandated changes to how Nutrition Facts panels will look, no such effort was done for changes in the Supplement Facts panel, so one trade group took the lead.
The nootropic category is again under that microscope as the Federal Trade Commission has announced the settlement of a case over unsupported cognitive support claims that generated a combined $26 million in fines.
The European Food Safety Authority (EFSA) has rejected a health claim related to a probiotic that claims to boost the immune system against pathogens in the gastrointestinal and respiratory tracts.
By Michael McGuffin, president, American Herbal Products Association
Looking back 25 years, there are several remarkable aspects of the Dietary Supplement Health and Education Act (DSHEA) amendments to the Food Drug and Cosmetic Act (FD&C Act), which transformed how dietary supplements are regulated.
The US Food and Drug Administration issued 11 warning letters yesterday to companies that have non NDI ingredients in their products. Eight of the warning letters concerned DMHA, with the other three concerned phenibut.
The Food and Drug Administration announced a new ‘rapid communication tool,’ called the Dietary Ingredient Advisory List. Trade groups and industry experts applauded the effort, but many opined that this step still has much left to be desired in terms...
The brilliant strategy of Sen. Orrin Hatch, the upswell of grassroots consumer pressure, and the ‘highly unusual’ personal intervention of an FDA Commissioner: The development and passage of the Dietary Supplement Health and Education Act is a fascinating...
As talk in the industry and at the FDA continues around the modernization of DSHEA, not everyone thinks big changes are needed. “The best thing the Agency does is inspect and test,” says NPA’s Dr Daniel Fabricant.
The European Food Safety Authority (EFSA)’s approval of additional uses of betaine comes with a caveat as the Agency warns sportspeople taking supplements containing the amino acid may exceed safe levels.
Should the creation of a new herbal medicine category be one of the goals of the upcoming discussions about a new regulatory framework? If it were possible, such a change could clear up many of the ambiguities surrounding the marketing of these products...
A leading vitamin K2 developer is working to establish a global K2-specific recommended daily intake as part of its heavyweight awareness campaign targeting health professionals, legislators and consumers.
With scientific advances and the growth of the dietary supplements industry on one hand, and the proliferation of adulterated and misbranded products on the other, the opportunity to modernize DSHEA couldn’t come at a better time.
Nestlé’s Dr Jörg Hager will deliver a keynote address at the second Healthy Ageing APAC Summit, where he will assess the changes needed in nutritional recommendations for an ageing population.
“Our board sees wisdom in admitting as CRN members those CBD companies who are playing by [the] rules," says CRN president and CEO
Having some companies specializing in the still-not-legal dietary ingredient CBD join CRN will help the trade group as it looks to “help FDA, or Congress, craft those regulations,” said Andrew Shao, CRN’s senior vice president of scientific and regulatory...
Select populations should avoid consuming food supplements containing glucosamine and/or chondroitin sulphate, French authorities warn after receiving a series of reported adverse events.
The recent slew of crackdowns, regulatory reviews and stricter rules for China's health food and supplement industry are 'growing pains' the industry must overcome, as regulators double down on efforts to promote safety and collect taxes.
FDA has reiterated its enforcment stance on CBD and hemp products, has updated a Q&A document on the subject and has specified what kind of information it is seeking in the runup to a public meeting on the subject in May, all as part of documents...
China's State Administration for Market Regulation (SAMR) is calling for public feedback regarding regulations for health food products containing probiotics.
FDA has sent three companies marketing CBD products warning letters over disease claims. The warnings are the first issued under FDA’s de facto ‘enforcement discretion’ policy, which will be discussed at a meeting on CBD set for the end of May.
The Council for Responsible Nutrition, a dietary supplements industry trade group, launched its Be Label Wise campaign targeting consumers to help them anticipate for upcoming changes in Supplement Facts labels.
Nu Skin China has formed a focus group, led by the firm's country CEO, to look into the death of a 34-year-old Chinese woman who died from organ failure after allegedly refusing medical treatment for flu and fever, and instead insisting on drinking...
The American Herbal Products Association (AHPA) has adopted a Guidance Policy for dietary supplement and food products that contain hemp and hemp-derived cannabidiol (CBD).
The Food Safety and Standards Association of India (FSSAI) has announced its collaboration with the Ministry of Ayush on possible standards for ayurvedic ahaar, or traditional ayurvedic foods, as a separate category.
The Puerto Rican commonwealth legislature has launched an investigation into what authorities it has to govern the dietary supplement industry, and what federal structures are already in place that pertain to the category.
Google stand accused of cashing in on unproven dementia supplements by selling advertising to retailers of “brain supplements,” flouting the search engine giant’s own advert and promotion policies.
Synthesized analogs of botanical ingredients, and ingredients of wholly artificial origin, could have a place in the dietary supplement industry. But if they do, full transparency would argue that they be labeled as such.
A victory for Natural Alternatives International in its beta alanine patent case is being heralded as a huge IP protection precedent in the natural products industry.
Germany's drug industry association the BPI has urged the European Union (EU) to clarify the current situation in which botanical foods and supplements can make unapproved health claims.
The proposed 2020 budget for FDA includes a request for mandatory registration of dietary supplements as well as decreased funding for research into these products, according to an analysis supplied to NutraIngredients-USA.
Evidence presented at the Novel Food Commission meeting this week has triggered a rethink for authorities over the decision to classify Cannabidiol (CBD) as a novel food (NF).
Six people and two companies have been charged by federal prosecutors for allegedly selling illegal drugs masquerading as supplements in a case filed Wednesday in Florida.
